Precision medicine for prostate cancer-improved outcome prediction for low-intermediate risk disease using a six-gene

William Lautert-Dutra1, Rodolfo Borges Dos Reis2, Jeremy A Squire3,4

  • 1Department of Genetics, Medicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.